CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ·Healthcare·Biotechnology
$4.05
—
Mkt Cap $5.91M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$12.50
Range $11.00 – $14.00
Implied Upside
+208.6%
Consensus $12.50 vs current $4.05
NASDAQ·Healthcare·Biotechnology
$4.05
—
Mkt Cap $5.91M
No recent rating data.
Price Target (2 analysts)
$12.50
Range $11.00 – $14.00
+208.6%
Consensus $12.50 vs current $4.05